BiotechTube
Home/IMUNON/Jeffrey W. Church
JW

Jeffrey W. Church

Interim Chief Financial Officer

IMUNON

Therapeutic Areas

OncologyInfectious Diseases

IMUNON Pipeline

DrugIndicationPhase
IMNN-001 (TheraPlas™-IL-12)Advanced Ovarian Cancer (Epithelial Ovarian Cancer)Phase 2
PlaCCine PlatformInfectious Diseases (e.g., SARS-CoV-2) & CancerPreclinical

Leadership Team at IMUNON

SR
Stacy R. Lindborg
President, Chief Executive Officer & Board Director
DV
Douglas V. Faller
Chief Medical Officer
KA
Khursheed Anwer
Executive Vice President and Chief Science Officer
SH
Sebastien Hazard
Executive Vice President & Chief Medical Officer
MH
Michael H. Tardugno
Board of Directors
FJ
Frederick J. Fritz
Board of Directors
DB
Donald Braun
Board of Directors
CP
Christine Pellizzari
Board of Directors
JE
James E. Dentzer
Board of Directors
View full IMUNON profile